Daphne Lainson is a partner in Smart & Biggar's Ottawa office where she specializes in securing patent protection for chemical, pharmaceutical and biotechnology related inventions. She is a lawyer, a qualified patent and trademark agent, and holds an advanced degree in chemistry. She has been assisting clients with securing patent protection for their innovations for over a decade.
Daphne champions and safeguards the intellectual property rights of her clients, protecting their inventions in new drugs, biologics, medical devices, consumer products, agrochemicals, specialty chemicals, industrial chemical processes, oil, gas and petrochemicals.
She also provides advice to clients on pharmaceutical regulatory law. This includes providing strategic advice during patent prosecution and following patent grant for both pharmaceuticals and biologics. She is called upon to advise innovative pharmaceutical and biopharmaceutical companies in matters relating to the Patented Medicines (Notice of Compliance) Regulations and the Patented Medicine Prices Review Board.
Daphne is sought after to provide advice and guidance to many of the top global innovators.
She is actively involved in the American Intellectual Property Law Association (AIPLA). She is currently the co-chair of the IP Practice in Japan Committee, immediate past chair of the AIPLA Mentoring Committee, and past chair of the AIPLA Women in Intellectual Property Law Committee.
She plays a leading role in client relations management within the firm, particularly in key industrial markets, such as the U.S., Japan and Germany.